TL;DR
Get oils, diffusers and self-care delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A study in Nature Communications links blood levels of the gut-bacteria-produced molecule imidazole propionate, or ImP, with Alzheimer’s-related biological markers and faster cognitive decline. Mouse experiments also found changes involving amyloid and tau, but the human findings are observational and do not show that ImP causes Alzheimer’s disease or that lowering it prevents the disease.
Researchers report that imidazole propionate (ImP), a molecule produced by some gut bacteria, is associated with Alzheimer’s-related biological markers and faster cognitive decline among people followed in Wisconsin research studies. The study, published in Nature Communications, also found in mice that ImP reaching the brain increased abnormal amyloid and tau accumulation; the results do not establish that the molecule causes Alzheimer’s disease in people.
The University of Wisconsin–Madison-led team studied ImP, a compound made by certain intestinal bacteria as they generate energy from histidine, an amino acid found in many foods. ImP production differs substantially among people. The researchers note that bacteria capable of producing it can be present even when they are not abundant, and that the molecule can pass from the gut into the bloodstream and reach other parts of the body.
In mouse experiments, the researchers found that ImP reaching the brain increased the accumulation of abnormal beta-amyloid and tau proteins, both associated with Alzheimer’s disease. The team also analyzed blood samples from nearly 1,200 participants in the Wisconsin Registry for Alzheimer’s Prevention and studies through the Wisconsin Alzheimer’s Disease Research Center. Higher blood ImP concentrations were associated with biological markers of abnormal proteins and impaired neuron function.
Because participants took cognitive tests over time, the team could compare ImP levels with changes in thinking and memory. Study co-author Federico Rey said participants with the highest ImP levels experienced faster cognitive decline. The report also describes a genetic variation linked to substantially higher blood ImP; about 43% of participants carried it. The researchers suspect the variation may affect how efficiently the kidneys clear ImP, but that explanation remains a hypothesis.
A Possible Route From Gut to Brain
The findings bring together a potential gut-to-brain mechanism, human blood measurements and cognitive follow-up, giving researchers a specific molecule to investigate in Alzheimer’s risk and progression. ImP has previously been linked in research to type 2 diabetes and coronary artery disease; this study adds brain-related findings, but does not establish that the molecule drives those conditions or dementia.
The work may help direct future prevention research toward reducing ImP itself rather than broadly changing the gut microbiome or cutting out a particular food. That distinction matters because histidine is an essential amino acid present in many protein-rich foods. The study does not show that a diet change, drug or other intervention that lowers ImP would reduce Alzheimer’s risk or slow decline.
probiotic supplements for gut health
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
The Team’s Earlier Gut Research
The study follows earlier work by University of Wisconsin–Madison researchers Barbara Bendlin and Rey, who nearly a decade ago reported differences in the gut microbial communities of people with Alzheimer’s disease and healthy individuals. Their continuing question has been how such differences might relate to changes in the brain. The new report focuses on a particular bacterial product, rather than treating all gut microbes as having the same effects.
ImP is made when some gut bacteria process histidine. Since the amino acid is needed by the body and occurs in a wide range of foods, the researchers caution against interpreting the results as a reason to eliminate foods such as eggs or red meat. Bendlin said general dietary improvement may help overall, but the study points toward investigating ways to target the molecule more directly.
“A microbe doesn’t have to be abundant to have an impact on the host.”
— Federico Rey, University of Wisconsin–Madison professor of bacteriology and study co-author
brain health supplements for memory
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Cause and Treatment Remain Unproven
The human results show an association between higher blood ImP and Alzheimer’s-related markers and cognitive decline; they do not prove that ImP caused either outcome. The mouse experiments provide evidence of effects in that model, but it remains unclear whether the same process occurs in people, or how much ImP contributes to an individual’s disease risk compared with other factors.
The report does not establish that lowering ImP prevents Alzheimer’s, slows symptoms or changes disease progression. It also does not specify a tested ImP-lowering treatment, the amount by which levels would need to fall, or whether the genetic variation affects kidney clearance as the researchers suspect. The reported 43% refers to participants in this study, not necessarily the wider population.
dietary supplements to support cognitive function
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Testing Ways to Lower ImP
The researchers say the findings could support work to identify an inhibitor that lowers ImP in the blood. Before such an approach could be considered a prevention or treatment, further studies would need to clarify the molecule’s role in people, test whether safely changing its levels affects relevant brain or cognitive outcomes, and assess any intervention in clinical trials. No timetable or planned trial was specified in the report.
For now, the study is a research finding, not a basis for changing diet or treatment. Its next significance will depend on whether other research confirms the relationship and whether a targeted way to alter ImP produces measurable benefits for people at risk of or living with dementia.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is imidazole propionate?
Imidazole propionate, or ImP, is a molecule made by certain gut bacteria as they process histidine, an amino acid. It can enter the bloodstream and, according to the study, reach the brain.
Does the study prove ImP causes Alzheimer’s disease?
No. The human findings show associations between blood ImP levels, Alzheimer’s-related biological markers and cognitive decline. The mouse experiments found effects involving amyloid and tau, but neither result proves that ImP causes Alzheimer’s in people.
Should people avoid foods containing histidine?
The researchers did not recommend avoiding particular foods. Histidine is essential and occurs in many foods, so the study does not support eliminating eggs, meat or other protein sources to lower ImP.
Is there a treatment that lowers ImP?
The report describes a possible future strategy of developing an inhibitor to reduce blood ImP. It does not report a tested or approved ImP-lowering treatment, or evidence that lowering ImP prevents or slows Alzheimer’s disease.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
